What medicine is good for small cell lung cancer

Now more and more people are suffering from small cell lung cancer, which is a very common cancer. If you have cancer, you should pay more attention to your diet, medication, and daily life. When you hear the name of small cell lung cancer, you should know that it is a lesion in the lungs. I believe that patients will feel very uncomfortable when they have a disease in the lungs. Let us learn about what medicine is good for small cell lung cancer.

Small cell lung cancer is one of the basic types of lung cancer. It belongs to undifferentiated cancer and is a highly malignant tumor. Small cell lung cancer has a shorter symptom period before diagnosis than other types of lung cancer, and a shorter survival period after diagnosis. If not treated, the median survival time of patients with small cell lung cancer from diagnosis is less than three months, and the two-year survival rate is less than 1%. Small cell carcinoma accounts for about 20% of all types of lung cancer. The onset age is relatively young, more common in men, and most patients have a history of smoking. It usually originates from larger bronchi, and most are central lung cancers. Small cell carcinoma has a low degree of differentiation, grows fast, and has early lymphatic metastasis and invasion of blood vessels through the blood vessels to widely metastasize to distant organs and tissues in the body. Therefore, among all types of lung cancer, small cell carcinoma has the worst prognosis. Small cell carcinoma is highly sensitive to radiotherapy and/or anticancer drug treatment. Surgery is generally not recommended for treatment, and systemic chemotherapy and radiotherapy are the main treatments. This type of lung cancer has a high degree of malignancy and a poor prognosis. Fever and cough are common symptoms of lung cancer in patients. Headache should be alert to brain metastasis, and a cranial CT scan is strongly recommended.

1. There are five chemotherapy drugs for small cell lung cancer in clinical practice, including platinum-containing and non-platinum regimens. Your current treatment plan mainly includes platinum, plus taxotere, isovinblastine. There are also combination treatments of taxotere and multiple drugs, such as taxotere plus cisplatin or carboplatin.

2. In short, small cell lung cancer is a highly malignant cancer that can easily transform into lung cancer. Moreover, most small cell lung cancers grow in larger bronchi, which are very easy to moisten the bronchial wall, thus blocking the tracheal cavity.

3. The age of onset of small cell lung cancer is generally around 60 years old, and its onset is closely related to smoking and occupational diseases. Clinical symptoms are generally cough, sputum, or lung infection, which are more common. Metastasis usually occurs when it is discovered.

Note: Although small cell lung cancer is relatively sensitive to radiotherapy and chemotherapy, it is also particularly prone to drug resistance. Early treatment is often more effective, but drug resistance will occur in the late stage.